Starpharma announced the retirement of Starpharma non-executive director, Richard Hazleton, effective at the conclusion of Annual General Meeting. This retirement is part of the Board's succession process and follows a transition period after the appointment of Mr. David McIntyre as an independent non-executive director on 1 March 2020.